Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Schmidt (Muenster, Germany), A. Schulze (Muenster, Germany), B. Heitkoetter (Muenster, Germany), G. Evers (Muenster, Germany), C. Schliemann (Muenster, Germany), K. Steinestel (Muenster, Germany), M. Trautmann (Muenster, Germany), A. Marra (Bremen, Germany), L. Hillejan (Ostercappeln, Germany), E. Wardelmann (Muenster, Germany), K. Rahbar (Muenster, Germany), D. Goerlich (Muenster, Germany), G. Lenz (Muenster, Germany), W. Berdel (Muenster, Germany), W. Hartmann (Muenster, Germany), M. Mohr (Muenster, Germany), S. Huss (Muenster, Germany), R. Wiewrodt (Muenster, Germany). Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer. 2784

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of p21 protein expression in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 The expression of central cell cycle regulators in non-small cell lung cancer has therapy-dependent prognostic impact Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Prognostic factors in non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient Source: Eur Respir J , 49 (4)  1602149; DOI: 10.1183/13993003.02149-2016 Year: 2017 XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer Source: Eur Respir J 2010; 36: 885-892 Year: 2010 Apelin expression is a prognostic factor in non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Effects of prognostic factors on survival of the patients of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 p-53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005